secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0000950170-25-070287
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics holds 2025 Annual Meeting; all proposals pass
------------------------------------------------------------------

- Thomas E. Hamilton elected Class II director with 46.5M votes for, 4.3M withheld.
- Advisory say-on-pay approved: 49.2M for, 1.4M against, 0.2M abstain.
- Ratification of PricewaterhouseCoopers as auditor for 2025: 57.7M for, 10.9K against.
- No other material proposals; all votes passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025070287/0000950170-25-070287-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025070287/lrmr-20250513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-070287

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer